ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

·ÅÉäºóÖÜϸ°ûËðÉËÒý·¢ÄÔËðÉ˵ÄлúÖÆ

¸å¼þȪԴ£º£º£ºËïÒÝÏɼÍÄîÒ½Ôº ±à¼­£º£º£ºÌ¸Ï£¡£¡£¡¢Íõ¶¬Ã· ÉóºË£º£º£ºÖª×ã ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±»Æî£¡£¡£¡¢³Ì½õƼ£©·ÅÉäÐÔÄÔËðÉË£¨radiation-induced brain injury£¬RIBI£©ÊÇÍ·¾±²¿Ö×Áö·ÅÁƺóÑÏÖØ²¢·¢Ö¢£¬ÁÙ´²ÌåÏÖΪÈÏÖªÕϰ­µÈ£¬²¡Àí¸Ä±äΪÄÔ×é֯ˮÖס¢»µËÀµÈ£¬Ö»¹ÜƤÖÊÀà¹Ì´¼ºÍ±´·¥µ¥¿¹ÏÖÔÚ¿É×÷ΪһÏßÖÎÁÆ£¬µ«ÈÔÓдó¶¼RIBI»¼Õß¶ÔÕâÁ½ÖÖÒ©ÎïÁÆÐ§²»²ÇÏë»òÓнû¼ÉÖ¢¡£Òò´Ë£¬ÆÈÇÐÐèÒª¿ª·¢ÐµĸüºÃµÄRIBIÖÎÁÆÒªÁì¡£

2023Äê2ÔÂ22ÈÕ£¬ËïÒÝÏɼÍÄîÒ½ÔºÄÔ¿ÆÑ§Ñо¿ÖÐÐÄ¡¢Éñ¾­¿ÆÌÆÑÇ÷½ÌÊÚÍŶÓÔÚScience Translational MedicineÔÓÖ¾ÉϽÒÏþÁËÌâΪ¡°A phase II study of thalidomide for the treatment of radiation-induced blood-brain barrier injury¡±µÄÑо¿ÂÛÎÄ£¬ÆÊÎöÁËɳÀû¶È°·Í¨¹ýÄæ×ªÖÜϸ°ûÖÐPDGFR¦ÂµÄ±í´ï¸ÄÉÆ·ÅÉäºóѪÄÔÆÁÕϺÍÄÔ¹à×¢µÄ»úÖÆ£¬Îª·ÅÉäÐÔÄÔËðÉ˵ÄÖÎÁÆÌá³öеĸÉÔ¤Õ½ÂÔ¡£

¸ÃÑо¿ÔÚ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÓÅÒìÇàÄêÏîÄ¿¡¢Öصã¹ú¼ÊÏàÖúÏîÄ¿µÈ»ù½ð×ÊÖúÏÂÍê³É£¬ËïÒÝÏɼÍÄîÒ½ÔºÄÔ¿ÆÑ§Ñо¿ÖÐÐÄ¡¢Éñ¾­¿ÆµÄ³Ì½õƼ²©Ê¿¡¢½ª¾²È㲩ʿ¡¢ºÎ°ØÝ沩ʿ¡¢ÁÖΰ½Ü¸±Ñо¿Ô±¼°ÀîÒÕÖ÷ÈÎҽʦΪÂÛÎÄÅäºÏµÚÒ»×÷Õߣ¬ÌÆÑÇ÷½ÌÊÚΪÂÛÎÄΨһͨѶ×÷Õß¡£


595F76DACD4F87AAA73C156AF06_3048C9E9_7C5B

ɳÀû¶È°·¶ÔRIBI»¼ÕßµÄDZÔÚÖÎÁÆÐ§¹û£º£º£ºSimonÁ½½×¶ÎÉè¼Æ


EAF4C50FAFD6FC4D48331F5EDB8_0AFDFAA3_A2BF

ɳÀû¶È°·¸ÄÉÆ·ÅÉäÐÔÄÔËðÉ˼°ÄÔ¹à×¢


AB8EE365BCE0A35D75CFD5C07A5_1B3CA8BD_15F6E

ɳÀû¶È°·Í¨¹ýPDGFR¦Â»Ö¸´·ÅÉäºóѪÄÔÆÁÕϵÄͨ͸ÐÔ


ɳÀû¶È°·ÊÇÒ»ÖֹȰ±ËáÑÜÉúÎ×îÔçÆÕ±éʹÓÃΪ¿¹ÍÂÄæºÍÕò¾²Ò©Îµ«ÓÉÓÚÖ»û×÷Ó㬸ÃÒ©Îï±»³·³öÊг¡¡£×î½üµÄÑо¿ÅúעɳÀû¶È°·¿ÉÔöǿѪ¹ÜÍêÕûÐÔ£¬ÔÚÖÎÁÆÎ¸³¦µÀ³öѪ¡¢ÒÅ´«ÐÔ³öѪÐÔëϸѪ¹ÜÀ©ÕÅÖ¢ºÍÄÔÐÂÎÅÂö»ûÐη½Ãæ¾ßÓнϺÃЧ¹û¡£ÖµµÃ×¢ÖØµÄÊÇ£¬ÁÙ´²ºÍ¶¯ÎïʵÑéÑо¿¾ùÅú×¢£¬·ÅÉäÓÕµ¼µÄ΢Ѫ¹ÜÆÆËðÔÚRIBIµÄ·¢²¡»úÖÆÖÐÆð×ÅÒªº¦×÷Ó㬵«É³Àû¶È°·ÊÇ·ñ¿Éͨ¹ý¸ÄÉÆ·ÅÉäÓÕµ¼µÄÄÔѪ¹Ü¹¦Ð§Õϰ­½ø¶ø¼õÇáÄÔËðÉËÉÐδÓÐÏà¹ØÑо¿±¨µÀ¡£

Ñо¿ÍŶÓÊ×ÏÈ¿ªÕ¹ÁËÒ»ÏîIIÆÚ¡¢µ¥±ÛǰհÐÔÊÔÑ飬Èë×é¶Ô±´·¥µ¥¿¹ºÍƤÖÊÀà¹Ì´¼ÁÆÐ§²»¼Ñ»òÓнû¼ÉÖ¢µÄRIBI»¼Õߣ¬½ÓÄÉsimon¶þ½×¶ÎÉè¼ÆÒªÁ죬ÒÔÑо¿É³Àû¶È°·µÄÁÆÐ§ºÍÇå¾²ÐÔ¡£ÔÚ¸ÃÑо¿Á½¸ö½×¶Î¹²ÄÉÈë58Ãû»¼Õߣ¬ÖÎÁÆ15Öܺó£¬27Ãû»¼ÕßÄÔË®Ö×Ìå»ýïÔÌ­¡Ý25%¡£±ðµÄ£¬Æ¾Ö¤Ïà¹ØÁ¿±í£¬Ñо¿»¹Õ¹ÏÖÁË43.1%»¼ÕßÓÐÁÙ´²Ö¢×´µÄ¸ÄÉÆ£»£»£»62.1%»¼ÕßÓÐÈÏÖªÆÀ·ÖµÄÌáÉý¡£Ñо¿ÖÐδ·ºÆð3¼¶ÒÔÉϵIJ»Á¼ÊÂÎñ£¬ÅúעɳÀû¶È°·¶ÔRIBIÖÎÁÆÓÐÓÃÇÒÇå¾²¡£

Ëæ×ÅÑо¿µÄ½øÒ»²½ÉîÈ룬ÍŶӻ¹Ì½ÌÖÁËɳÀû¶È°·ÖÎÁÆ·ÅÉäÐÔÄÔËðÉ˵ĻúÖÆ¡£»£»£»¼Õß¹¦Ð§´Å¹²Õñ³ÉÏñÏÔʾ£¬É³Àû¶È°·¸øÒ©ºó¿ÉÐÞ¸´ËðÉËÄÔÇøµÄѪÄÔÆÁÕÏÍêÕûÐÔ¼°ÑªÒºµÄ¹©Ó¦¡£¶¯ÎïʵÑé֤ʵ£¬·ÅÉä½µµÍÁËëϸѪ¹ÜÖÜϸ°ûÖÐPDGFR¦ÂÂѰ׵ıí´ï£¬½éµ¼·ÅÉäºóѪÄÔÆÁÕϵÄͨ͸ÐÔÔöÌí£¬¶øÉ³Àû¶È°·¿Éͨ¹ýÄæ×ªPDGFR¦ÂÂѰ׵ıí´ï¡¢¼õÇáÖÜϸ°ûÐÎ̬¸Ä±äÀ´»Ö¸´ÑªÄÔÆÁÕÏÍêÕûÐÔ¼°Î¢Ñ­»·¹à×¢£¬½ø¶øÐÞ¸´ÊÜËðÉñ¾­Ôª×îÖÕ¸ÄÉÆÈÏÖª¹¦Ð§¡£

ͨ¹ýÁÙ´²ÊÔÑéºÍ»ù´¡Ñо¿Á¬ÏµµÄģʽ£¬Ñо¿Ð§¹û֤ʵÁËɳÀû¶È°·ÔÚ·ÅÉäºóÄÔСѪ¹ÜËðÉ˺ÍÈÏÖª¹¦Ð§Õϰ­·½Ãæ¾ßÓÐÓÅÒìµÄÖÎÁÆÐ§¹û£¬ÎªÁÙ´²ÄÑÖÎÐÔ·ÅÉäÐÔÄÔËðÉË»¼ÕßÌṩÁËеÄÖÎÁÆÑ¡ÔñºÍʱ»ú¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.science.org/doi/10.1126/scitranslmed.abm6543


¡¾ÍøÕ¾µØÍ¼¡¿